COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Wei-Qin Zhao

Dr. Wei-Qin Zhao

Scientific Review Officer



Biography

Division:
Division of Neuroscience, Development and Aging DNDA
IRG:
Brain Disorders and Clinical Neuroscience BDCN
Study Section:
Clinical Neuroimmunology and Brain Tumors CNBT

Dr. Wei-Qin Zhao received her medical training from Sun Yat-sen University of Medical Sciences in China, and a Ph.D. in neurobiology from LaTrobe University in Australia. She worked as a postdoctoral fellow in LaTrobe University, a lecturer in Monash University, Australia, and as a visiting fellow at the National Institute of Neurological Disorders and Stroke, NIH. She then took a position of associate professor at Blanchette Rockefeller Neurosciences Institute, followed by a visiting scholar at Northwestern University. Prior to joining CSR, she was a senior research biologist at Merck Research Laboratories. Dr Zhao’s past research interests were in molecular/cellular mechanisms underlying learning and memory, and drug discovery for cognitive disorders such as Alzheimer’s disease and schizophrenia.